Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Escherichia coli clonobiome: assessing the strains diversity in feces and urine by deep amplicon sequencing.

Shevchenko SG, Radey M, Tchesnokova V, Kisiela D, Sokurenko EV.

Appl Environ Microbiol. 2019 Sep 20. pii: AEM.01866-19. doi: 10.1128/AEM.01866-19. [Epub ahead of print]

PMID:
31540992
2.

Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women.

Tchesnokova VL, Rechkina E, Chan D, Haile HG, Larson L, Ferrier K, Schroeder DW, Solyanik T, Shibuya S, Hansen K, Ralston JD, Riddell K, Scholes D, Sokurenko EV.

Clin Infect Dis. 2019 Jul 4. pii: ciz547. doi: 10.1093/cid/ciz547. [Epub ahead of print]

PMID:
31271206
3.

Pandemic fluoroquinolone resistant Escherichia coli clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci.

Tchesnokova V, Radey M, Chattopadhyay S, Larson L, Weaver JL, Kisiela D, Sokurenko EV.

Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14740-14748. doi: 10.1073/pnas.1903002116. Epub 2019 Jul 1.

PMID:
31262826
4.

Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193.

Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, Fang FC, Ralston J, Riddell K, Scholes D, Weissman S, Parker K, Spellberg B, Johnson JR, Sokurenko EV.

Clin Infect Dis. 2019 Jan 7;68(2):334-337. doi: 10.1093/cid/ciy525.

5.

The Uropathogenic Escherichia coli Subclone Sequence Type 131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic.

Tchesnokova V, Riddell K, Scholes D, Johnson JR, Sokurenko EV.

Clin Infect Dis. 2019 Feb 15;68(5):781-787. doi: 10.1093/cid/ciy523.

6.

CHTyper, a Web Tool for Subtyping of Extraintestinal Pathogenic Escherichia coli Based on the fumC and fimH Alleles.

Roer L, Johannesen TB, Hansen F, Stegger M, Tchesnokova V, Sokurenko E, Garibay N, Allesøe R, Thomsen MCF, Lund O, Hasman H, Hammerum AM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e00063-18. doi: 10.1128/JCM.00063-18. Print 2018 Apr. No abstract available.

7.

Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.

Miles-Jay A, Weissman SJ, Adler AL, Tchesnokova V, Sokurenko EV, Baseman JG, Zerr DM.

Clin Infect Dis. 2018 Jan 18;66(3):411-419. doi: 10.1093/cid/cix805.

8.

Development of a Web Tool for Escherichia coli Subtyping Based on fimH Alleles.

Roer L, Tchesnokova V, Allesøe R, Muradova M, Chattopadhyay S, Ahrenfeldt J, Thomsen MCF, Lund O, Hansen F, Hammerum AM, Sokurenko E, Hasman H.

J Clin Microbiol. 2017 Aug;55(8):2538-2543. doi: 10.1128/JCM.00737-17. Epub 2017 Jun 7.

9.

Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Kisiela DI, Radey M, Paul S, Porter S, Polukhina K, Tchesnokova V, Shevchenko S, Chan D, Aziz M, Johnson TJ, Price LB, Johnson JR, Sokurenko EV.

J Bacteriol. 2017 Jun 13;199(13). pii: e00036-17. doi: 10.1128/JB.00036-17. Print 2017 Jul 1.

10.

Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection.

Tchesnokova V, Avagyan H, Rechkina E, Chan D, Muradova M, Haile HG, Radey M, Weissman S, Riddell K, Scholes D, Johnson JR, Sokurenko EV.

PLoS One. 2017 Mar 28;12(3):e0174132. doi: 10.1371/journal.pone.0174132. eCollection 2017.

11.

Clonal distribution and associated characteristics of Escherichia coli clinical and surveillance isolates from a military medical center.

Manges AR, Mende K, Murray CK, Johnston BD, Sokurenko EV, Tchesnokova V, Johnson JR.

Diagn Microbiol Infect Dis. 2017 Apr;87(4):382-385. doi: 10.1016/j.diagmicrobio.2017.01.007. Epub 2017 Jan 20.

PMID:
28139277
12.

SpyB, a Small Heme-Binding Protein, Affects the Composition of the Cell Wall in Streptococcus pyogenes.

Edgar RJ, Chen J, Kant S, Rechkina E, Rush JS, Forsberg LS, Jaehrig B, Azadi P, Tchesnokova V, Sokurenko EV, Zhu H, Korotkov KV, Pancholi V, Korotkova N.

Front Cell Infect Microbiol. 2016 Oct 13;6:126. eCollection 2016.

13.

Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection.

Leatham-Jensen MP, Mokszycki ME, Rowley DC, Deering R, Camberg JL, Sokurenko EV, Tchesnokova VL, Frimodt-Møller J, Krogfelt KA, Leth Nielsen K, Frimodt-Møller N, Sun G, Cohen PS.

mSphere. 2016 Jan 20;1(1). pii: e00055-15. doi: 10.1128/mSphere.00055-15. eCollection 2016 Jan-Feb.

14.

The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.

Johnson JR, Thuras P, Johnston BD, Weissman SJ, Limaye AP, Riddell K, Scholes D, Tchesnokova V, Sokurenko E.

Clin Infect Dis. 2016 Jun 15;62(12):1529-1536. doi: 10.1093/cid/ciw193. Epub 2016 Mar 29.

15.

A Novel 7-Single Nucleotide Polymorphism-Based Clonotyping Test Allows Rapid Prediction of Antimicrobial Susceptibility of Extraintestinal Escherichia coli Directly From Urine Specimens.

Tchesnokova V, Avagyan H, Billig M, Chattopadhyay S, Aprikian P, Chan D, Pseunova J, Rechkina E, Riddell K, Scholes D, Fang FC, Johnson JR, Sokurenko EV.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofw002. doi: 10.1093/ofid/ofw002. eCollection 2016 Jan.

16.

Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.

Johnson JR, Porter SB, Thuras P, Johnson TJ, Price LB, Tchesnokova V, Sokurenko EV.

Antimicrob Agents Chemother. 2015 Nov;59(11):7132-5. doi: 10.1128/AAC.01687-15. Epub 2015 Aug 31.

17.

Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.

Tchesnokova VL, Ottley LL, Sakamoto K, Fierer J, Sokurenko E, Liss MA.

Urology. 2015 Dec;86(6):1200-5. doi: 10.1016/j.urology.2015.07.008. Epub 2015 Aug 20.

18.

Erratum for Johnson et al., intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli.

Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.

Antimicrob Agents Chemother. 2015 Sep;59(9):5871. doi: 10.1128/AAC.01716-15. No abstract available.

19.

Inactive conformation enhances binding function in physiological conditions.

Yakovenko O, Tchesnokova V, Sokurenko EV, Thomas WE.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9884-9. doi: 10.1073/pnas.1503160112. Epub 2015 Jul 27.

20.

Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.

Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.

Antimicrob Agents Chemother. 2015 Aug;59(8):4471-80. doi: 10.1128/AAC.00673-15. Epub 2015 May 18. Erratum in: Antimicrob Agents Chemother. 2015 Sep;59(9):5871.

21.

Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli.

Kisiela DI, Avagyan H, Friend D, Jalan A, Gupta S, Interlandi G, Liu Y, Tchesnokova V, Rodriguez VB, Sumida JP, Strong RK, Wu XR, Thomas WE, Sokurenko EV.

PLoS Pathog. 2015 May 14;11(5):e1004857. doi: 10.1371/journal.ppat.1004857. eCollection 2015 May.

22.

Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.

Dahbi G, Mora A, Mamani R, López C, Alonso MP, Marzoa J, Blanco M, Herrera A, Viso S, García-Garrote F, Tchesnokova V, Billig M, de la Cruz F, de Toro M, González-López JJ, Prats G, Chaves F, Martínez-Martínez L, López-Cerezo L, Denamur E, Blanco J.

Int J Med Microbiol. 2014 Nov;304(8):1247-57. doi: 10.1016/j.ijmm.2014.10.002. Epub 2014 Oct 14.

PMID:
25455219
23.

Methane-fed microbial microcosms show differential community dynamics and pinpoint taxa involved in communal response.

Oshkin IY, Beck DA, Lamb AE, Tchesnokova V, Benuska G, McTaggart TL, Kalyuzhnaya MG, Dedysh SN, Lidstrom ME, Chistoserdova L.

ISME J. 2015 May;9(5):1119-29. doi: 10.1038/ismej.2014.203. Epub 2014 Oct 21.

24.

Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.

Peirano G, van der Bij AK, Freeman JL, Poirel L, Nordmann P, Costello M, Tchesnokova VL, Pitout JD.

Antimicrob Agents Chemother. 2014 Jul;58(7):3762-7. doi: 10.1128/AAC.02428-14. Epub 2014 Apr 21.

25.

Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients - an unrecognized CF pathogen?

Barillova P, Tchesnokova V, Dübbers A, Küster P, Peters G, Dobrindt U, Sokurenko EV, Kahl BC.

Int J Med Microbiol. 2014 May;304(3-4):415-21. doi: 10.1016/j.ijmm.2014.02.008. Epub 2014 Feb 19.

PMID:
24630795
26.

Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E.

J Clin Microbiol. 2014 May;52(5):1358-65. doi: 10.1128/JCM.03502-13. Epub 2014 Feb 5.

27.

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV.

MBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.

28.

Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Kisiela DI, Rodriguez VB, Tchesnokova V, Avagyan H, Aprikian P, Liu Y, Wu XR, Thomas WE, Sokurenko EV.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19089-94. doi: 10.1073/pnas.1314395110. Epub 2013 Nov 4.

29.

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.

Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):6385-8. doi: 10.1128/AAC.01604-13. Epub 2013 Sep 30.

30.

The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):5912-7. doi: 10.1128/AAC.01065-13. Epub 2013 Sep 16.

31.

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.

Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.

32.

Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome.

Tchesnokova V, Billig M, Chattopadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova V, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV.

J Clin Microbiol. 2013 Sep;51(9):2991-9. doi: 10.1128/JCM.00984-13. Epub 2013 Jul 10.

33.

Allosteric coupling in the bacterial adhesive protein FimH.

Rodriguez VB, Kidd BA, Interlandi G, Tchesnokova V, Sokurenko EV, Thomas WE.

J Biol Chem. 2013 Aug 16;288(33):24128-39. doi: 10.1074/jbc.M113.461376. Epub 2013 Jul 2.

34.

Evolutionary analysis points to divergent physiological roles of type 1 fimbriae in Salmonella and Escherichia coli.

Kisiela DI, Chattopadhyay S, Tchesnokova V, Paul S, Weissman SJ, Medenica I, Clegg S, Sokurenko EV.

MBio. 2013 Mar 5;4(2). pii: e00625-12. doi: 10.1128/mBio.00625-12.

35.

Tight conformational coupling between the domains of the enterotoxigenic Escherichia coli fimbrial adhesin CfaE regulates binding state transition.

Liu Y, Esser L, Interlandi G, Kisiela DI, Tchesnokova V, Thomas WE, Sokurenko E, Xia D, Savarino SJ.

J Biol Chem. 2013 Apr 5;288(14):9993-10001. doi: 10.1074/jbc.M112.413534. Epub 2013 Feb 7.

36.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933. Epub 2013 Jan 3.

37.

Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli.

Paul S, Linardopoulou EV, Billig M, Tchesnokova V, Price LB, Johnson JR, Chattopadhyay S, Sokurenko EV.

J Bacteriol. 2013 Jan;195(2):231-42. doi: 10.1128/JB.01524-12. Epub 2012 Nov 2.

38.

Evolution of Salmonella enterica virulence via point mutations in the fimbrial adhesin.

Kisiela DI, Chattopadhyay S, Libby SJ, Karlinsey JE, Fang FC, Tchesnokova V, Kramer JJ, Beskhlebnaya V, Samadpour M, Grzymajlo K, Ugorski M, Lankau EW, Mackie RI, Clegg S, Sokurenko EV.

PLoS Pathog. 2012;8(6):e1002733. doi: 10.1371/journal.ppat.1002733. Epub 2012 Jun 7.

39.

High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli.

Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Scholes D, Chattopadhyay S, Sokurenko E.

Appl Environ Microbiol. 2012 Mar;78(5):1353-60. doi: 10.1128/AEM.06663-11. Epub 2012 Jan 6.

40.

Adaptive evolution of class 5 fimbrial genes in enterotoxigenic Escherichia coli and its functional consequences.

Chattopadhyay S, Tchesnokova V, McVeigh A, Kisiela DI, Dori K, Navarro A, Sokurenko EV, Savarino SJ.

J Biol Chem. 2012 Feb 24;287(9):6150-8. doi: 10.1074/jbc.M111.303735. Epub 2012 Jan 3.

41.

Allosteric catch bond properties of the FimH adhesin from Salmonella enterica serovar Typhimurium.

Kisiela DI, Kramer JJ, Tchesnokova V, Aprikian P, Yarov-Yarovoy V, Clegg S, Sokurenko EV.

J Biol Chem. 2011 Nov 4;286(44):38136-47. doi: 10.1074/jbc.M111.237511. Epub 2011 Jul 27.

42.

Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.

Tchesnokova V, Aprikian P, Kisiela D, Gowey S, Korotkova N, Thomas W, Sokurenko E.

Infect Immun. 2011 Oct;79(10):3895-904. doi: 10.1128/IAI.05169-11. Epub 2011 Jul 18.

43.

The bacterial fimbrial tip acts as a mechanical force sensor.

Aprikian P, Interlandi G, Kidd BA, Le Trong I, Tchesnokova V, Yakovenko O, Whitfield MJ, Bullitt E, Stenkamp RE, Thomas WE, Sokurenko EV.

PLoS Biol. 2011 May;9(5):e1000617. doi: 10.1371/journal.pbio.1000617. Epub 2011 May 10.

44.

Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting.

Le Trong I, Aprikian P, Kidd BA, Forero-Shelton M, Tchesnokova V, Rajagopal P, Rodriguez V, Interlandi G, Klevit R, Vogel V, Stenkamp RE, Sokurenko EV, Thomas WE.

Cell. 2010 May 14;141(4):645-55. doi: 10.1016/j.cell.2010.03.038.

45.

Shear-enhanced binding of intestinal colonization factor antigen I of enterotoxigenic Escherichia coli.

Tchesnokova V, McVeigh AL, Kidd B, Yakovenko O, Thomas WE, Sokurenko EV, Savarino SJ.

Mol Microbiol. 2010 Apr;76(2):489-502. doi: 10.1111/j.1365-2958.2010.07116.x. Epub 2010 Mar 25.

46.

Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli.

Stahlhut SG, Tchesnokova V, Struve C, Weissman SJ, Chattopadhyay S, Yakovenko O, Aprikian P, Sokurenko EV, Krogfelt KA.

J Bacteriol. 2009 Nov;191(21):6592-601. doi: 10.1128/JB.00786-09. Epub 2009 Sep 4.

47.

Escherichia coli DraE adhesin-associated bacterial internalization by epithelial cells is promoted independently by decay-accelerating factor and carcinoembryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin.

Korotkova N, Yarova-Yarovaya Y, Tchesnokova V, Yazvenko N, Carl MA, Stapleton AE, Moseley SL.

Infect Immun. 2008 Sep;76(9):3869-80. doi: 10.1128/IAI.00427-08. Epub 2008 Jun 16.

48.

FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation.

Yakovenko O, Sharma S, Forero M, Tchesnokova V, Aprikian P, Kidd B, Mach A, Vogel V, Sokurenko E, Thomas WE.

J Biol Chem. 2008 Apr 25;283(17):11596-605. doi: 10.1074/jbc.M707815200. Epub 2008 Feb 21.

49.

Integrin-like allosteric properties of the catch bond-forming FimH adhesin of Escherichia coli.

Tchesnokova V, Aprikian P, Yakovenko O, Larock C, Kidd B, Vogel V, Thomas W, Sokurenko E.

J Biol Chem. 2008 Mar 21;283(12):7823-33. doi: 10.1074/jbc.M707804200. Epub 2008 Jan 3.

50.

The cysteine bond in the Escherichia coli FimH adhesin is critical for adhesion under flow conditions.

Nilsson LM, Yakovenko O, Tchesnokova V, Thomas WE, Schembri MA, Vogel V, Klemm P, Sokurenko EV.

Mol Microbiol. 2007 Sep;65(5):1158-69.

Supplemental Content

Loading ...
Support Center